1
Clinical Trials associated with Dendritic cell vaccine(West China Second University Hospital) / Not yet recruitingPhase 1IIT Dendritic Cell Vaccination for the Adult Ovarian Cancer
Effective treatments are desperately needed for ovarian cancer patients. This phase I clinical trial assesses the safety of a novel personalized dendritic-cell vaccine administered to ovarian cancer patients. Secondary outcomes will be evaluated such as patient pharmacodynamics, progression-free survival and overall survival.
100 Clinical Results associated with Dendritic cell vaccine(West China Second University Hospital)
100 Translational Medicine associated with Dendritic cell vaccine(West China Second University Hospital)
100 Patents (Medical) associated with Dendritic cell vaccine(West China Second University Hospital)
100 Deals associated with Dendritic cell vaccine(West China Second University Hospital)